Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

A novel approach to generating morbillivirus vaccines: negatively marking the rinderpest vaccine.

Vaccine - 2 Mar 2012

Buczkowski Hubert, Parida Satya, Bailey Dalan, Barrett Thomas, Banyard Ashley C

Abstract excerpt

The eradication of rinderpest virus (RPV) from the globe was possible through the availability of a safe and effective live attenuated vaccine and a suitable companion diagnostic test. However, the inability to serologically 'Differentiate between naturally Infected and Vaccinated Animals' (DIVA) meant that both the time taken to complete the eradication programme and the economic burden on countries involved was...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Binding Sites, Antibody
Share to Chlorocebus aethiops

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Epitopes

Share to Hemagglutinins, Viral

Share to Peptide Library

Share to Vaccines, DNA

Share to Vero Cells

Share to Viral Vaccines

Source

Identifiers

PMID: 22265946
DOI: 10.1016/j.vaccine.2012.01.029

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

A novel approach to generating morbillivirus vaccines: negatively marking the rinderpest vaccine.PMID 22265946Read ↗

Rescue of a vaccine strain of peste des petits ruminants virus: In vivo evaluation and comparison with standard vaccineSemantic proximity Read ↗

Harnessing Attenuation-Related Mutations of Viral Genomes: Development of a Serological Assay to Differentiate between Capripoxvirus-Infected and -Vaccinated Animals.Semantic proximity Read ↗

Development of a genetically marked recombinant rinderpest vaccine expressing green fluorescent proteinSemantic proximity Read ↗

Recombinant Rinderpest Vaccines Expressing Membrane-Anchored Proteins as Genetic Markers: Evidence of Exclusion of Marker Protein from the Virus EnvelopeSemantic proximity Read ↗

Generation of recombinant mAbs to vaccinia virus displaying high affinity and potent neutralizationSemantic proximity Read ↗

Immunogenicity and protective efficacy of 3A truncated negative marker foot-and-mouth disease virus serotype A vaccine.Semantic proximity Read ↗

Rational Attenuation of a Morbillivirus by Modulating the Activity of the RNA-Dependent RNA PolymeraseSemantic proximity Read ↗

Development of a live attenuated antigenic marker classical swine fever vaccine.Semantic proximity Read ↗

Characterization of monoclonal antibodies against foot-and-mouth disease virus serotype O and application in identification of antigenic variation in relation to vaccine strain selection.Semantic proximity Read ↗

Identification of immunodominant neutralizing epitopes on the hemagglutinin protein of rinderpest virus.Semantic proximity Read ↗

A Safe Foot-and-Mouth Disease Vaccine Platform with Two Negative Markers for Differentiating Infected from Vaccinated AnimalsSemantic proximity Read ↗

Development of a Dual Recombinant Vaccine To Protect Small Ruminants against Peste-des-Petits-Ruminants Virus and Capripoxvirus InfectionsSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.